1 Enasidenib Market Overview 1.1 Product Overview and Scope of Enasidenib 1.2 Enasidenib Segment by Type 1.2.1 Global Enasidenib Sales Growth Rate Comparison by Type (2020-2026) 1.2.2 50mg 1.2.3 100mg 1.3 Enasidenib Segment by Application 1.3.1 Enasidenib Sales Comparison by Application: (2020-2026) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Enasidenib Market Size Estimates and Forecasts 1.4.1 Global Enasidenib Revenue 2015-2026 1.4.2 Global Enasidenib Sales 2015-2026 1.4.3 Enasidenib Market Size by Region: 2020 Versus 2026 2 Global Enasidenib Market Competition by Manufacturers 2.1 Global Enasidenib Sales Market Share by Manufacturers (2015-2020) 2.2 Global Enasidenib Revenue Share by Manufacturers (2015-2020) 2.3 Global Enasidenib Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Enasidenib Manufacturing Sites, Area Served, Product Type 2.5 Enasidenib Market Competitive Situation and Trends 2.5.1 Enasidenib Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Enasidenib Players (Opinion Leaders) 3 Enasidenib Retrospective Market Scenario by Region 3.1 Global Enasidenib Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Enasidenib Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Enasidenib Market Facts & Figures by Country 3.3.1 North America Enasidenib Sales by Country 3.3.2 North America Enasidenib Sales by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Enasidenib Market Facts & Figures by Country 3.4.1 Europe Enasidenib Sales by Country 3.4.2 Europe Enasidenib Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Enasidenib Market Facts & Figures by Region 3.5.1 Asia Pacific Enasidenib Sales by Region 3.5.2 Asia Pacific Enasidenib Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Enasidenib Market Facts & Figures by Country 3.6.1 Latin America Enasidenib Sales by Country 3.6.2 Latin America Enasidenib Sales by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Enasidenib Market Facts & Figures by Country 3.7.1 Middle East and Africa Enasidenib Sales by Country 3.7.2 Middle East and Africa Enasidenib Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Enasidenib Historic Market Analysis by Type 4.1 Global Enasidenib Sales Market Share by Type (2015-2020) 4.2 Global Enasidenib Revenue Market Share by Type (2015-2020) 4.3 Global Enasidenib Price Market Share by Type (2015-2020) 4.4 Global Enasidenib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Enasidenib Historic Market Analysis by Application 5.1 Global Enasidenib Sales Market Share by Application (2015-2020) 5.2 Global Enasidenib Revenue Market Share by Application (2015-2020) 5.3 Global Enasidenib Price by Application (2015-2020) 6 Company Profiles and Key Figures in Enasidenib Business 6.1 Celgene Corporation 6.1.1 Corporation Information 6.1.2 Celgene Corporation Description, Business Overview 6.1.3 Celgene Corporation Enasidenib Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Celgene Corporation Products Offered 6.1.5 Celgene Corporation Recent Development 7 Enasidenib Manufacturing Cost Analysis 7.1 Enasidenib Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Enasidenib 7.4 Enasidenib Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Enasidenib Distributors List 8.3 Enasidenib Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Enasidenib Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Enasidenib by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Enasidenib by Type (2021-2026) 10.2 Enasidenib Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Enasidenib by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Enasidenib by Application (2021-2026) 10.3 Enasidenib Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Enasidenib by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Enasidenib by Region (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Enasidenib Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Enasidenib Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Enasidenib Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Enasidenib Manufacturers Covered in This Study Table 5. Global Enasidenib Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Enasidenib Sales Share by Manufacturers (2015-2020) Table 7. Global Enasidenib Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Enasidenib Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Enasidenib Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Enasidenib Sales Sites and Area Served Table 11. Manufacturers Enasidenib Product Types Table 12. Global Enasidenib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Enasidenib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enasidenib as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Enasidenib Players Table 16. Global Enasidenib Sales (K Units) by Region (2015-2020) Table 17. Global Enasidenib Sales Market Share by Region (2015-2020) Table 18. Global Enasidenib Revenue (Million US$) by Region (2015-2020) Table 19. Global Enasidenib Revenue Market Share by Region (2015-2020) Table 20. North America Enasidenib Sales by Country (2015-2020) (K Units) Table 21. North America Enasidenib Sales Market Share by Country (2015-2020) Table 22. North America Enasidenib Revenue by Country (2015-2020) (US$ Million) Table 23. North America Enasidenib Revenue Market Share by Country (2015-2020) Table 24. Europe Enasidenib Sales by Country (2015-2020) (K Units) Table 25. Europe Enasidenib Sales Market Share by Country (2015-2020) Table 26. Europe Enasidenib Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Enasidenib Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Enasidenib Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Enasidenib Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Enasidenib Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Enasidenib Revenue Market Share by Region (2015-2020) Table 32. Latin America Enasidenib Sales by Country (2015-2020) (K Units) Table 33. Latin America Enasidenib Sales Market Share by Country (2015-2020) Table 34. Latin America Enasidenib Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Enasidenib Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Enasidenib Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Enasidenib Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Enasidenib Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Enasidenib Revenue Market Share by Country (2015-2020) Table 40. Global Enasidenib Sales (K Units) by Type (2015-2020) Table 41. Global Enasidenib Sales Share by Type (2015-2020) Table 42. Global Enasidenib Revenue (Million US$) by Type (2015-2020) Table 43. Global Enasidenib Revenue Share by Type (2015-2020) Table 44. Global Enasidenib Price (USD/Unit) by Type (2015-2020) Table 45. Global Enasidenib Sales (K Units) by Application (2015-2020) Table 46. Global Enasidenib Sales Market Share by Application (2015-2020) Table 47. Global Enasidenib Sales Growth Rate by Application (2015-2020) Table 48. Celgene Corporation Corporation Information Table 49. Celgene Corporation Description and Business Overview Table 50. Celgene Corporation Enasidenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Celgene Corporation Main Product Table 52. Celgene Corporation Recent Development Table 53. Production Base and Market Concentration Rate of Raw Material Table 54. Key Suppliers of Raw Materials Table 55. Enasidenib Distributors List Table 56. Enasidenib Customers List Table 57. Enasidenib Market Trends Table 58. Enasidenib Opportunities and Drivers Table 59. Enasidenib Market Challenges Table 60. Global Enasidenib Sales (K Units) Forecast by Type (2021-2026) Table 61. Global Enasidenib Sales Market Share Forecast by Type (2021-2026) Table 62. Global Enasidenib Revenue (Million US$) Forecast by Type (2021-2026) Table 63. Global Enasidenib Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 64. Global Enasidenib Sales (K Units) Forecast by Application (2021-2026) Table 65. Global Enasidenib Revenue (Million US$) Forecast by Application (2021-2026) Table 66. Global Enasidenib Sales (K Units) Forecast by Region (2021-2026) Table 67. Global Enasidenib Sales Market Share Forecast by Region (2021-2026) Table 68. Global Enasidenib Revenue Forecast by Region (2021-2026) (US$ Million) Table 69. Global Enasidenib Revenue Market Share Forecast by Region (2021-2026) Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Enasidenib Figure 2. Global Enasidenib Sales Market Share by Type: 2020 VS 2026 Figure 3. 50mg Product Picture Figure 4. 100mg Product Picture Figure 5. Global Enasidenib Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Figure 7. Pharmacy Figure 8. Global Enasidenib Market Size 2015-2026 (US$ Million) Figure 9. Global Enasidenib Sales Capacity (K Units) (2015-2026) Figure 10. Global Enasidenib Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Enasidenib Sales Share by Manufacturers in 2020 Figure 12. Global Enasidenib Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Enasidenib Revenue in 2019 Figure 14. Enasidenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Enasidenib Sales Market Share by Region (2015-2020) Figure 16. Global Enasidenib Sales Market Share by Region in 2019 Figure 17. Global Enasidenib Revenue Market Share by Region (2015-2020) Figure 18. Global Enasidenib Revenue Market Share by Region in 2019 Figure 19. North America Enasidenib Sales Market Share by Country in 2019 Figure 20. North America Enasidenib Revenue Market Share by Country in 2019 Figure 21. the United States Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 22. the United States Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Enasidenib Sales Market Share by Country in 2019 Figure 26. Europe Enasidenib Revenue Market Share by Country in 2019 Figure 27. Germany Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 30. France Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. UK Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 32. UK Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Enasidenib Sales Market Share by Region in 2019 Figure 38. Asia Pacific Enasidenib Revenue Market Share by Region in 2019 Figure 39. China Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 40. China Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 46. India Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Enasidenib Sales Market Share by Country in 2019 Figure 62. Latin America Enasidenib Revenue Market Share by Country in 2019 Figure 63. Mexico Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Enasidenib Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Enasidenib Revenue Market Share by Country in 2019 Figure 71. Turkey Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. UAE Enasidenib Sales Growth Rate (2015-2020) (K Units) Figure 76. UAE Enasidenib Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Enasidenib by Type (2015-2020) Figure 78. Sales Market Share of Enasidenib by Type in 2020 Figure 79. Global Enasidenib Market Share by Price Range (2015-2020) Figure 80. Revenue Market Share of Enasidenib by Type in 2019 Figure 81. Global Enasidenib Sales Growth by Type (2015-2020) (K Units) Figure 82. Sales Market Share of Enasidenib by Application (2015-2020) Figure 83. Sales Market Share of Enasidenib by Application in 2020 Figure 84. Revenue Share of Enasidenib by Application (2015-2020) Figure 85. Revenue Share of Enasidenib by Application in 2020 Figure 86. Key Raw Materials Price Trend Figure 87. Manufacturing Cost Structure of Enasidenib Figure 88. Manufacturing Process Analysis of Enasidenib Figure 89. Enasidenib Industrial Chain Analysis Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Porter's Five Forces Analysis Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

Celgene Corporation